檢索結果 - Elizabeth Fox

Refine Results
  1. 1
    Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics

    Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics 由 Elizabeth Fox-Edmiston, Judy Van de Water

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Clinical Trial Design for Target-Based Therapy

    Clinical Trial Design for Target-Based Therapy 由 Elizabeth Fox, Gregory A. Curt, Frank M. Balis

    出版 2002
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Maternal and fetal antibrain antibodies in development and disease

    Maternal and fetal antibrain antibodies in development and disease 由 Elizabeth Fox, David G. Amaral, Judy Van de Water

    出版 2012
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

    Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors 由 Robin E. Norris, Peter C. Adamson, Vu Thuong Nguyen, Elizabeth Fox

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates

    Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates 由 Shana Jacobs, Cynthia Lester McCully, Robert F. Murphy, John Bacher, Frank M. Balis, Elizabeth Fox

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

    Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group 由 AeRang Kim, Brigitte C. Widemann, Mark Krailo, Nalini Jayaprakash, Elizabeth Fox, Brenda J. Weigel, Susan M. Blaney

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors

    Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents... 由 Elizabeth Fox, Brigitte C. Widemann, Devang Pastakia, Clara C. Chen, Sherry Yang, Diane E. Cole, Frank M. Balis

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas

    Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas 由 A. Kim, Andrea Gillespie, Eva Dombi, Anne Goodwin, Wendy Goodspeed, Elizabeth Fox, Frank M. Balis, Brigitte C. Widemann

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma

    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma 由 Frank M. Balis, Christine M. Busch, Ami V. Desai, Emily Hibbitts, Arlene Naranjo, Rochelle Bagatell, Meredith S. Irwin, Elizabeth Fox

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials

    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group earl... 由 Wendy B. London, Rochelle Bagatell, Brenda J. Weigel, Elizabeth Fox, Dongjing Guo, Collin Van Ryn, Arlene Naranjo, Julie R. Park

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    New Agents, Emerging Late Effects, and the Development of Precision Survivorship

    New Agents, Emerging Late Effects, and the Development of Precision Survivorship 由 Eric J. Chow, Zoltan Antal, Louis S. Constine, Rebecca Gardner, William H. Wallace, Brent R. Weil, Jennifer M. Yeh, Elizabeth Fox

    出版 2018
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals

    Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals 由 Verónica Martínez-Cerdeño, Jasmin Camacho, Elizabeth Fox, Elaine N. Miller, Jeanelle Ariza, Devon Kienzle, Kaela Plank, Stephen C. Noctor, Judy Van de Water

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient

    Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient 由 Aikaterini A. Nella, Maya Lodish, Elizabeth Fox, Frank M. Balis, Martha Quezado, Patricia Whitcomb, Joanne Derdak, Electron Kebebew, Brigitte C. Widemann, Constantine A. Stratakis

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600–Mutant Low-Grade Glioma

    Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600–Mutant Low-Grade Glioma 由 Éric Bouffet, Birgit Geoerger, Christopher L. Moertel, James A. Whitlock, Isabelle Aerts, Darren Hargrave, Lisa Osterloh, Eugene Tan, Jeea Choi, Mark W. Russo, Elizabeth Fox

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

    Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Al... 由 Elizabeth Fox, Shreyaskumar Patel, J. Kyle Wathen, Scott M. Schuetze, Sant P. Chawla, David C. Harmon, Denise K. Reinke, Rashmi Chugh, Robert S. Benjamin, Lee J. Helman

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

    Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncol... 由 Rochelle Bagatell, Robin E. Norris, Ashish M. Ingle, Charlotte H. Ahern, Stephan D. Voss, Elizabeth Fox, Anthony Little, Brenda J. Weigel, Peter C. Adamson, Susan M. Blaney

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study

    Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Con... 由 Yaël P. Mossé, Emily Lipsitz, Elizabeth Fox, David T. Teachey, John M. Maris, Brenda J. Weigel, Peter C. Adamson, Mark A. Ingle, Charlotte H. Ahern, Susan M. Blaney

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)

    A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot... 由 James I. Geller, Elizabeth Fox, Brian Turpin, Stuart L. Goldstein, Xiaowei Liu, Charles G. Minard, Rachel A. Kudgus, Joel M. Reid, Stacey L. Berg, Brenda J. Weigel

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

    A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412 由 Kara L. Davis, Elizabeth Fox, Emasenyie Isikwei, Joel M. Reid, Xiaowei Liu, Charles G. Minard, Stephan D. Voss, Stacey L. Berg, Brenda J. Weigel, Crystal L. Mackall

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report

    Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report 由 Jack Su, Lindsay Kilburn, David B. Mansur, Mark Krailo, Allen Buxton, Adesina Adekunle, Amar Gajjar, Peter C. Adamson, Brenda J. Weigel, Elizabeth Fox, Susan M. Blaney, Maryam Fouladi

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: